Crosbie Phil A J, Shah Rajesh, Krysiak Piotr, Zhou Cong, Morris Karen, Tugwood Jonathan, Booton Richard, Blackhall Fiona, Dive Caroline
Manchester Thoracic Oncology Centre, North West Lung Centre, University Hospital of South Manchester, Manchester, United Kingdom; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester, United Kingdom; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, United Kingdom.
Manchester Thoracic Oncology Centre, North West Lung Centre, University Hospital of South Manchester, Manchester, United Kingdom; Cancer Research UK Lung Cancer Centre of Excellence, Manchester, United Kingdom; Department of Thoracic Surgery, University Hospital of South Manchester, Manchester, United Kingdom.
J Thorac Oncol. 2016 Oct;11(10):1793-7. doi: 10.1016/j.jtho.2016.06.017. Epub 2016 Jul 25.
Tumor recurrence after surgical resection of NSCLC obstructs long-term disease-free survival in approximately 50% of cases. Our data suggest that combining circulating tumor cell enumeration (as single cells or clusters) in tumor-draining pulmonary vein and peripheral blood (assessed by CellSearch) at the time of NSCLC surgery better identifies those patients at higher risk for lung cancer recurrence than does peripheral circulating tumor cell number alone.
非小细胞肺癌手术切除后的肿瘤复发阻碍了约50%病例的长期无病生存。我们的数据表明,在非小细胞肺癌手术时,结合肿瘤引流肺静脉和外周血中循环肿瘤细胞计数(作为单个细胞或细胞簇,通过CellSearch评估)比单独的外周循环肿瘤细胞数量能更好地识别那些肺癌复发风险较高的患者。